UPDATE : Monday, September 7, 2020
상단여백
Samsung BioLogics agrees to manufacture CytoDyn’s HIV drug
Samsung BioLogics said it has signed a deal with U.S. biotech firm CytoDyn ...
by Jeong Sae-im  |  2019-05-31 14:59
라인
Announcement of Invossa license revocation was ‘procedural breach’: Kolon
The government’s recent announcement that it would nullify the license of I...
by Jeong Sae-im  |  2019-05-30 13:28
라인
Medytox suspected of GMP violation filed at anti-corruption commission
Medytox, the Korean botulinum toxin maker, is suspected of breaching Good M...
by Jeong Sae-im  |  2019-05-27 15:52
라인
‘Shareholders can surely win lawsuit against Kolon’
Law firm Hankyul is pursuing a lawsuit against Kolon Life Science and Kolon...
by Jeong Sae-im  |  2019-05-24 19:34
라인
[News Focus] Kolon, regulator rapped for not doing enough to quell concerns of patients
More than 50 days have passed since the Ministry of Food and Drug Safety (M...
by Jeong Sae-im  |  2019-05-22 11:59
라인
Legislator, activists call for revoking Invossa license, conducting probes
A lawmaker and civic groups urged the government to nullify the license of ...
by Jeong Sae-im  |  2019-05-21 16:03
라인
[Reporter’s Notebook] ‘Wanna know what’s going on with MSD Korea?’
“Is there any trouble between Korea Biomedical Review and MSD Korea?”People...
by Jeong Sae-im  |  2019-05-21 11:44
라인
Kolon to follow 3,700 Invossa-treated patients for 15 years
Kolon Life Science said it would conduct a long-term follow-up study on ove...
by Jeong Sae-im  |  2019-05-17 15:38
라인
Will Celltrion CEO’s bet on ‘bio valley’ pay off?
“It’s been 19 years since I started this business. The first decade was a t...
by Jeong Sae-im  |  2019-05-17 13:21
라인
CHA Biotech’s operating income plunges 92% in Q1
CHA Biotech said in a public filing on Wednesday that it recorded 124.4 bil...
by Jeong Sae-im  |  2019-05-16 13:41
라인
KangStem Biotech completes stem cell drug plant
“KangStem Biotech aims to become a leader in the global stem cell therapy m...
by Jeong Sae-im  |  2019-05-16 11:27
라인
Samsung BioLogics in tight spot amid probe, shareholders’ lawsuit
Prosecutors are speeding up the probe into Samsung BioLogics for alleged ac...
by Jeong Sae-im  |  2019-05-14 14:10
라인
‘MSD Korea’s foreign exec got drunk, sexually harassed female worker’
A foreign executive at MSD Korea not only sexually harassed a female employ...
by Jeong Sae-im  |  2019-05-14 11:53
라인
Celltrion’s operating income down 33% in Q1
Biopharmaceutical firm Celltrion said it suffered a 32.9 percent decline in...
by Jeong Sae-im  |  2019-05-09 15:26
라인
If Invossa license gets revoked, Kolon should return $13 million to Mundipharma
The licensing deal between Kolon Life Science and Mundipharma for osteoarth...
by Jeong Sae-im  |  2019-05-08 15:33
라인
Mobile healthcare firm Noom raises $58 million for biz expansion
Noom, a New York-based mobile healthcare company, said it has attracted $58...
by Jeong Sae-im  |  2019-05-08 15:23
라인
Inspection will clear all suspicions over Invossa: TissueGene
Kolon TissueGene finally broke silence amid a growing suspicion that it mig...
by Jeong Sae-im  |  2019-05-08 14:32
라인
Kolon might have covered up Invossa mislabeling for 2 years
Kolon TissueGene said in a public filing that it notified its parent compan...
by Jeong Sae-im  |  2019-05-07 15:55
라인
[Exclusive] MSD workers appalled by executive’s remarks on childcare leave
MSD Korea recently revised a policy to allow employees on child care leave ...
by Jeong Sae-im  |  2019-05-07 12:08
라인
Civic group files complaint against Kolon, regulator
A non-government consumer group has complained with the prosecution against...
by Jeong Sae-im  |  2019-04-30 14:59
여백
여백
여백
Back to Top